Technology News and Research

RSS
Special issue of FMCH focuses on care and disease management interventions in China, Australia

Special issue of FMCH focuses on care and disease management interventions in China, Australia

Innovative tool helps observe protein aggregates linked to neurodegenerative diseases

Innovative tool helps observe protein aggregates linked to neurodegenerative diseases

Clear Guide SCENERGY CT-Ultrasound fusion system receives FDA 510(k) clearance

Clear Guide SCENERGY CT-Ultrasound fusion system receives FDA 510(k) clearance

Diagnostic imaging equipment market in Saudi Arabia expected to grow at CAGR of 7.9% during 2015-2020

Diagnostic imaging equipment market in Saudi Arabia expected to grow at CAGR of 7.9% during 2015-2020

IRIDEX's Cyclo G6 laser system receives CE Mark approval for treatment of glaucoma

IRIDEX's Cyclo G6 laser system receives CE Mark approval for treatment of glaucoma

Johns Hopkins engineers successfully use mind-controlled prosthetic arm to control movements of fingers

Johns Hopkins engineers successfully use mind-controlled prosthetic arm to control movements of fingers

Electronic health records could help identify people who have undiagnosed type 2 diabetes

Electronic health records could help identify people who have undiagnosed type 2 diabetes

First two patients treated in multi-center clinical trial for perivascular renal denervation

First two patients treated in multi-center clinical trial for perivascular renal denervation

Regrowing dopaminergic neurons may lead to new therapy for Parkinson's disease

Regrowing dopaminergic neurons may lead to new therapy for Parkinson's disease

Amgen announces availability of Kyprolis (carfilzomib) in the UK for treatment of relapsed multiple myeloma

Amgen announces availability of Kyprolis (carfilzomib) in the UK for treatment of relapsed multiple myeloma

IoT Tech Expo Europe 2016: It's time for large corporates to engage with SMEs, says EveryWare

IoT Tech Expo Europe 2016: It's time for large corporates to engage with SMEs, says EveryWare

NICE issues positive guidance for use of Medtronic insulin therapy systems for managing Type 1 diabetes

NICE issues positive guidance for use of Medtronic insulin therapy systems for managing Type 1 diabetes

Proof-of-concept data for NanoString's Hyb & Seq chemistry presented at AGBT Meeting

Proof-of-concept data for NanoString's Hyb & Seq chemistry presented at AGBT Meeting

First patients dosed in Neurotrope's Bryostatin-1 Phase 2b trial for treatment of advanced Alzheimer’s disease

First patients dosed in Neurotrope's Bryostatin-1 Phase 2b trial for treatment of advanced Alzheimer’s disease

Telemedicine market in the U.S. estimated to cross $ 13 billion by 2021

Telemedicine market in the U.S. estimated to cross $ 13 billion by 2021

Wake Forest Baptist scientists prove feasibility of printing living tissue structures for surgical implantation

Wake Forest Baptist scientists prove feasibility of printing living tissue structures for surgical implantation

Confirming nasogastric tube placement through an assay? An interview with Ian Fotheringham

Confirming nasogastric tube placement through an assay? An interview with Ian Fotheringham

Survey: Some patients with multiple sclerosis not engaging with specialist services

Survey: Some patients with multiple sclerosis not engaging with specialist services

Newly launched programme aims to speed up commercialisation of digital health technologies

Newly launched programme aims to speed up commercialisation of digital health technologies

TUM researchers make progress in bringing immunotherapy to fight against cancer, infectious diseases

TUM researchers make progress in bringing immunotherapy to fight against cancer, infectious diseases

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.